KCM
GSK icon

Karp Capital Management’s GSK GSK Stock Holding History

Karp Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1
Closed – – 220
2018
Q4 		$0 Buy
+1
New +$49 ﹤0.01% 405
2015
Q4 		– Sell
-366
Closed -$18K – 169
2015
Q3 		$18K Hold
366
– – 0.01% 238
2015
Q2 		$19K Buy
+366
New +$20.6K 0.01% 252

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Karp Capital Management's GSK Position: Q1 2019 in Review

Karp Capital Management sold out of GSK (GSK) in Q1 2019, closing a stake of 1 share.

Karp Capital Management first reported a position in GSK in Q2 2015 and held it in 3 quarters. The position peaked at $19K in Q2 2015. 847 funds tracked by Wall St. Rank hold GSK as of Q1 2019.

  • Karp Capital Management reported no remaining GSK position as of Q1 2019 after selling out during the quarter.
  • Karp Capital Management sold 1 GSK share in Q1 2019.
  • Karp Capital Management first reported a position in GSK in Q2 2015 and held it in 3 quarters.
  • Karp Capital Management's GSK position peaked at $19K in Q2 2015.
  • 847 funds tracked by Wall St. Rank held GSK as of Q1 2019.

Based on Karp Capital Management's 13F filing for Q1 2019, filed 7 May 2019.